A systematic review of primary active surveillance management of low-risk papillary carcinoma

被引:19
|
作者
Alhashemi, Ahmad [1 ]
Goldstein, David P. [2 ,3 ]
Sawka, Anna M. [1 ,4 ]
机构
[1] Univ Toronto, Dept Med, Div Endocrinol, Toronto, ON, Canada
[2] Univ Hlth Network, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada
[3] Univ Toronto, Toronto, ON, Canada
[4] Univ Hlth Network, Dept Med, Div Endocrinol, Toronto, ON, Canada
关键词
active surveillance; papillary thyroid cancer; thyroid carcinoma; thyroidectomy; DIFFERENTIATED THYROID-CARCINOMA; THERAPEUTIC STRATEGY; ENDOCRINE SURGEONS; SURGICAL-TREATMENT; JAPANESE SOCIETY; UNITED-STATES; PATIENT AGE; CANCER; MICROCARCINOMA; ASSOCIATION;
D O I
10.1097/CCO.0000000000000244
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose of review Active surveillance is close follow-up of neoplasms, with predetermined intervention triggers. We systematically reviewed the published English language literature on primary active surveillance of low-risk papillary thyroid cancer (PTC). Recent findings We searched seven electronic databases (1980-2015), supplemented with a hand search. Two reviewers independently screened 1715 citations and reviewed 32 full-text papers, ultimately including two papers. Data were independently abstracted. There were two Japanese single-center, single-arm studies reporting on 1235 and 322 patients with PTC microcarcinoma (primary <1 cm in diameter) confined to the thyroid. Mean study follow-up was of 5.0 and 6.5 years, respectively. Disease triggers for thyroidectomy included progression of the primary tumor or incident metastatic disease. The rates of thyroidectomy were 15.5% (191/1235) and 8.7% (28/322) in respective studies. The incidence of primary tumor enlargement >= 3 mm in maximal diameter was 4.6% (58/1235) and 5.0% (16/322). The incidence of nodal metastases was 1.5% (19/1235) and 0.9% (3/322). There were neither reports of PTC-related death nor development of distant metastatic disease. Quality of life, psychosocial health, and economic outcomes were not reported. Summary In two Japanese single-arm studies, active surveillance of PTC microcarcinoma was relatively well tolerated; however, more long-term outcome research is needed.
引用
收藏
页码:11 / 17
页数:7
相关论文
共 50 条
  • [41] Active surveillance vs. surgery in low-risk papillary thyroid microcarcinoma patients and the risk of loss to follow-up
    Saito, Yoshiyuki
    Matsuzu, Kenichi
    Takami, Hiroshi
    Matsui, Ai
    Kuga, Yoko
    Ohara, Ryoji
    Yoshioka, Kana
    Masaki, Chie
    Akaishi, Junko
    Hames, Kiyomi Y.
    Okamura, Ritsuko
    Tomoda, Chisato
    Suzuki, Akifumi
    Kitagawa, Wataru
    Nagahama, Mitsuji
    Sugino, Kiminori
    Ito, Koichi
    CANCER MEDICINE, 2024, 13 (16):
  • [42] Tumor Growth Kinetics Based on Initial Tumor Volume Doubling Time in Active Surveillance of Low-Risk Papillary Thyroid Carcinoma
    Kim, Chae A.
    Baek, Seung Hee
    Yoo, Jungmin
    Chung, Sae Rom
    Baek, Jung Hwan
    Chung, Ki-Wook
    Kim, Won Bae
    Jeon, Min Ji
    Kim, Won Gu
    THYROID, 2024, 34 (07) : 846 - 855
  • [43] Active surveillance of low-risk papillary thyroid cancer: A meta-analysis
    Saravana-Bawan, Bianka
    Bajwa, Amandeep
    Paterson, John
    McMullen, Todd
    SURGERY, 2020, 167 (01) : 46 - 54
  • [44] Active Surveillance for Small Papillary Thyroid Cancer: A Systematic Review and Meta-Analysis
    Cho, Se Jin
    Suh, Chong Hyun
    Baek, Jung Hwan
    Chung, Sae Rom
    Choi, Young Jun
    Chung, Ki-Wook
    Shong, Young Kee
    Lee, Jeong Hyun
    THYROID, 2019, 29 (10) : 1399 - 1408
  • [45] Patient-Reported Outcomes in Patients with Low-Risk Papillary Thyroid Carcinoma: Cross-Sectional Study to Compare Active Surveillance and Immediate Surgery
    Kazusaka, Hiroko
    Sugitani, Iwao
    Toda, Kazuhisa
    Sen, Masaomi
    Saito, Marie
    Nagaoka, Ryuta
    Yoshida, Yusaku
    WORLD JOURNAL OF SURGERY, 2023, 47 (05) : 1190 - 1198
  • [46] National Survey of Endocrinologists and Surgeons Regarding Active Surveillance for Low-Risk Papillary Thyroid Cancer
    Roman, Benjamin R.
    Brito, Juan P.
    Saucke, Megan C.
    Lohia, Shivangi
    Jensen, Catherine B.
    Zaborek, Nick
    Jennings, Jamia Linn
    Tuttle, Robert M.
    Davies, Louise
    Pitt, Susan C.
    ENDOCRINE PRACTICE, 2021, 27 (01) : 1 - 7
  • [47] Mortality Risk of Nonoperative Papillary Thyroid Carcinoma: A Corollary for Active Surveillance
    Ho, Allen S.
    Luu, Michael
    Zalt, Cynthia
    Morris, Luc G. T.
    Chen, Irene
    Melany, Michelle
    Ali, Nabilah
    Patio, Chrysanta
    Chen, Yufei
    St-Clair, Jon Mallen
    Braunstein, Glenn D.
    Sacks, Wendy L.
    Zumsteg, Zachary S.
    THYROID, 2019, 29 (10) : 1409 - 1417
  • [48] Effectiveness of routine ultrasonographic surveillance of patients with low-risk papillary carcinoma of the thyroid
    Wang, Laura Y.
    Roman, Benjamin R.
    Palmer, Frank L.
    Tuttle, R. Michael
    Shaha, Ashok R.
    Shah, Jatin P.
    Patel, Snehal G.
    Ganly, Ian
    SURGERY, 2016, 159 (05) : 1390 - 1395
  • [49] Outcomes of Conversion Surgery for Patients With Low-Risk Papillary Thyroid Carcinoma
    Levyn, Helena
    Scholfield, Daniel W.
    Eagan, Alana
    Boe, Lillian A.
    Shaha, Ashok R.
    Wong, Richard J.
    Shah, Jatin P.
    Ganly, Ian
    Morris, Luc G. T.
    Tuttle, R. Michael
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2024, : 1058 - 1065
  • [50] Implementing active surveillance for low-risk thyroid carcinoma into clinical practice: collaborative recommendations for Latin America
    Sanabria, Alvaro
    Ferraz, Carolina
    Ku, Chih Hao Chen
    Padovani, Rosalia
    Palacios, Karen
    Paz, Jose Luis
    Roman, Alejandro
    Smulever, Anabella
    Vaisman, Fernanda
    Pitoia, Fabian
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2024, 68